According to a new report from Irish research company GMR Data, the global healthcare packaging market will grow to $262bn by 2028, rising from $117.2bn across 2018.

In a recent GMR Data report, figures indicate that revenues for the dermatology drug market will reach $83.2 billion in 2026 from a base of $31.6 billion in 2016.

The largest dermatology drug markets in 2016 include areas such as acne, worth $3.89 billion globally, skin infections ($6.59 billion), and skin cancer ($5.06 billion).

Robust sales in western markets, entrance of new drugs into emerging markets, and increasing prevalence of skin conditions are all driving the global forecast for the next decade.

The Chinese economy has grown substantially from a GDP of $1,931 billion in 2004 to reach $10,355 billion across 2014, a 10-year CAGR of 10.3%. Many analysts forecast that Chinese GDP will surpass US GDP, currently the globe's largest, by 2020; some forecast even sooner. This rise in GDP has been mirrored across many sectors in China, with increased levels of spending in public infrastructure, manufacturing, healthcare and many, many other domestic industries.

The global smoking cessation market is going from strength to strength, globally, with ever increasing products coming to the market both prescription and over-the-counter (OTC). Most notable are the range of Vaping (e-cigarettes/smokeless cigarettes) products, a market which was estimated to be worth over $3 billion across both 2013 and 2014. So, where has this market come from?